CD19 and diffuse large B-cell lymphoma: These products are indicated for several CD19+ B-cell malignancies, including B-cell acute lymphoblastic leukemia (B-ALL), diffuse large B-cell lymphoma (DLBCL), and mantle cell lymphoma (MCL).